Hanall Biopharma Co (XKRX:009420) FCF Margin % : 3.16% (As of Dec. 2023)

View and export this data going back to 1989. Start your Free Trial

What is Hanall Biopharma Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Hanall Biopharma Co's Free Cash Flow for the three months ended in Dec. 2023 was ₩1,001 Mil. Hanall Biopharma Co's Revenue for the three months ended in Dec. 2023 was ₩31,718 Mil. Therefore, Hanall Biopharma Co's FCF Margin % for the quarter that ended in Dec. 2023 was 3.16%.

As of today, Hanall Biopharma Co's current FCF Yield % is 1.17%.

The historical rank and industry rank for Hanall Biopharma Co's FCF Margin % or its related term are showing as below:

XKRX:009420' s FCF Margin % Range Over the Past 10 Years
Min: -8.8 Med: -2.43 Max: 47.41
Current: 15.15

During the past 13 years, the highest FCF Margin % of Hanall Biopharma Co was 47.41%. The lowest was -8.80%. And the median was -2.43%.

XKRX:009420's FCF Margin % is ranked better than
84.8% of 1026 companies
in the Drug Manufacturers industry
Industry Median: -0.695 vs XKRX:009420: 15.15

Hanall Biopharma Co FCF Margin % Historical Data

The historical data trend for Hanall Biopharma Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanall Biopharma Co FCF Margin % Chart

Hanall Biopharma Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

11.26

-7.29

-8.03

15.99

15.15

Hanall Biopharma Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															3.43	19.18	-12.20	57.55	3.16

Competitive Comparison of Hanall Biopharma Co's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Hanall Biopharma Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hanall Biopharma Co's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hanall Biopharma Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Hanall Biopharma Co's FCF Margin % falls into.

Hanall Biopharma Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Hanall Biopharma Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	20445.253	/	134909.838
	=	15.15 %

Hanall Biopharma Co's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	1001.33	/	31718.153
	=	3.16 %

Hanall Biopharma Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Hanall Biopharma Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hanall Biopharma Co (XKRX:009420) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hanall Biopharma Co Ltd (XKRX:009420) » Definitions » FCF Margin %

Traded in Other Exchanges

N/A

Address

12 Bongeunsa-ro 114-gil, Daewoong Building, 3rd Floor, Gangnam-gu, Seoul, KOR

Website

http://www.hanall.co.kr

Hanall Biopharma Co Ltd is a part of the healthcare sector. It is one of Korea's leading pharmaceutical companies and is focused on drug delivery, biotherapeutics, and new small molecule discovery. The company's scope comprises of ophthalmology, immunology, cardiovascular treatment and dermatology.

Hanall Biopharma Co (XKRX:009420) Headlines

No Headlines